The global aerosol delivery devices market was valued at $31,463.9 million in 2019, and is projected to reach $46,728.7 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Aerosol delivery devices are hand-held, portable drug delivery devices. They consist of suspension of solid or liquid particles in a carrier gas, which makes feasible for treatment of respiratory and non-respiratory diseases. There are different forms of drugs available for aerosol drug delivery such as dry powder, solution, and suspension. It is the most advanced mode of drug administration in which aerosolized drug is directly delivered to lungs to offer a systemic effect. Aerosol delivery devices are available in three types, namely, dry powder inhalers, metered dose inhalers, and nebulizers. Aerosol drug delivery is a natural therapy and easiest way to treat respiratory diseases such as asthma, COPD, and cystic fibrosis. Moreover, it is used to deliver insulin, analgesic medications, and other drugs as well.
Rise in prevalence of asthma, COPD, and other respiratory disorders, an increase in smoking population, ease of administration of drug with aerosol delivery devices, rise in demand for metered-dose inhalers, technological advancements in inhaler devices, and rise in geriatric population are the key factors that fuel growth of the global aerosol delivery devices market. For instance, according to the WHO, in 2018, more than 339 million people were affected by asthma worldwide. Moreover, rise in adoption of aerosol delivery devices by patients, an increase in patient awareness toward inhalation therapy, surge in preference of pulmonary route of drug delivery, rise in urbanization and pollution levels, an increase in incidences of preterm births and lifestyle changes, and increase in the number of R&D activities to develop ideal inhalation therapy are other factors that contribute toward growth of the market. However, complications and side-effects associated with drug inhalation and high cost associated with nebulizers are expected to hinder growth of the market.
The global aerosol delivery devices market is segmented into product, application, and distribution channel. By product, the market is categorized into dry powder inhalers, metered dose inhalers, and nebulizers. The dry powder inhalers segment is further bifurcated into single dose inhalers and multi dose inhalers. The metered dose inhalers segment is further divided into conventional pressurized inhalers and soft mist inhalers. The nebulizers segment is further categorized into jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. On the basis of application, the market is segregated into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and non-respiratory diseases. The non-respiratory diseases segment is further divided is into diabetes, analgesia, and Parkinson’s disease. Depending on distribution channel, the market is classified into retail pharmacies, hospital pharmacies, and e-commerce. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Stakeholders
Key Market Segments
By Product
By Application
By Distribution Channel
By Region
LIST OF KEY PLAYERS PROFILED IN THE REPORT
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Rise in prevalence of asthma, COPD, and other respiratory disorders, an increase in smoking population, ease of administration of drug with aerosol delivery devices, rise in demand for metered-dose inhalers, technological advancements in inhaler devices, and rise in geriatric population are the key factors that fuel growth of the global aerosol delivery devices market. For instance, according to the WHO, in 2018, more than 339 million people were affected by asthma worldwide. Moreover, rise in adoption of aerosol delivery devices by patients, an increase in patient awareness toward inhalation therapy, surge in preference of pulmonary route of drug delivery, rise in urbanization and pollution levels, an increase in incidences of preterm births and lifestyle changes, and increase in the number of R&D activities to develop ideal inhalation therapy are other factors that contribute toward growth of the market. However, complications and side-effects associated with drug inhalation and high cost associated with nebulizers are expected to hinder growth of the market.
The global aerosol delivery devices market is segmented into product, application, and distribution channel. By product, the market is categorized into dry powder inhalers, metered dose inhalers, and nebulizers. The dry powder inhalers segment is further bifurcated into single dose inhalers and multi dose inhalers. The metered dose inhalers segment is further divided into conventional pressurized inhalers and soft mist inhalers. The nebulizers segment is further categorized into jet nebulizers, ultrasonic wave nebulizers, and vibrating mesh nebulizers. On the basis of application, the market is segregated into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and non-respiratory diseases. The non-respiratory diseases segment is further divided is into diabetes, analgesia, and Parkinson’s disease. Depending on distribution channel, the market is classified into retail pharmacies, hospital pharmacies, and e-commerce. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive analysis of four regions is provided to determine the existing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
Key Market Segments
By Product
- Dry powder inhalers
- Single dose inhalers
- Multi dose inhalers
- Metered dose inhalers
- Conventional pressurized inhalers,
- Soft mist inhalers
- Nebulizers
- Jet nebulizers
- Ultrasonic wave nebulizers
- Vibrating mesh nebulizers
By Application
- Asthma
- Chronic obstructive pulmonary disease
- Cystic fibrosis
- Non respiratory diseases
- Diabetes
- Analgesia
- Parkinson’s disease
By Distribution Channel
- Retail pharmacies
- Hospital pharmacies
- E-commerce
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- 3M Company
- Aerogen, Inc.
- Glaxosmithkline Plc (GSK)
- Johnson & Johnson (Actelion Pharmaceuticals Ltd)
- Koninklijke Philips N.V.
- Merck & Co. Inc.
- Metall Zug Group (Clement Clarke International Ltd)
- Recipharm AB (Bespak)
- Teva Pharmaceutical Industries Limited
- Vectura Group Plc
- Gerresheimer AG
- Heitkamp & Thumann KG (H&T Presspart)
- Iconovo AB
- Merxin Ltd
- Nemera
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
- AstraZeneca Plc
- Boehringer Ingelheim GmbH
- Novartis AG
Table of Contents
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Landscape
Chapter 4: Aerosol Delivery Devices Market, by Product
Chapter 5: Aerosol Delivery Devices Market, by Application
Chapter 6: Aerosol Delivery Devices Market, by Distribution Channel
Chapter 7: Aerosol Delivery Devices Market, by Region
Chapter 8: Company Profiles
Chapter 9: Application Based Company Profiles
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 277 |
| Published | August 2020 |
| Forecast Period | 2019 - 2027 |
| Estimated Market Value ( USD | $ 31463.9 million |
| Forecasted Market Value ( USD | $ 46728.7 million |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
